Alkyl Amines Chemicals Ltd

Alkyl Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Alkyl Amines Chemicals Ltd

₹ 1,977 -0.32%
13 Dec - close price
alkylamines.com BSE: 506767 NSE: ALKYLAMINE
About

Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.

Key Points

Business Leadership
The co. offers 100+ products, it is a global leader in many products including acetonitrile, DEHA, DMA-HCLA, and Triethylamine. [1]

Website BSE NSE
  • Market Cap ₹ 10,108 Cr.
  • Current Price ₹ 1,977
  • High / Low ₹ 2,735 / 1,805
  • Stock P/E 60.1
  • Book Value ₹ 257
  • Dividend Yield 0.51 %
  • ROCE 16.5 %
  • ROE 12.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 19.0%
  • Company has been maintaining a healthy dividend payout of 26.5%

Cons

  • Stock is trading at 7.70 times its book value
  • The company has delivered a poor sales growth of 11.2% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE 400 MidSmallCap Index BSE 500 Nifty 500 BSE 250 SmallCap Index Nifty Smallcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
349 377 425 473 409 388 412 410 352 322 357 400 415
273 310 352 358 328 319 335 336 304 262 288 321 341
Operating Profit 75 67 73 116 81 70 78 74 48 60 69 79 74
OPM % 22% 18% 17% 24% 20% 18% 19% 18% 14% 19% 19% 20% 18%
4 5 4 4 2 5 2 5 2 5 3 5 9
Interest 1 1 1 1 1 1 1 1 2 1 1 0 0
Depreciation 8 8 12 12 11 11 12 12 13 17 17 18 18
Profit before tax 71 62 65 107 71 63 67 66 36 46 53 66 64
Tax % 24% 26% 28% 24% 27% 27% 28% 25% 25% 28% 28% 26% 26%
54 46 46 82 52 46 49 50 27 33 38 49 47
EPS in Rs 10.59 8.98 9.09 16.03 10.26 8.94 9.52 9.74 5.33 6.54 7.52 9.56 9.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
366 446 476 484 501 616 846 993 1,242 1,542 1,683 1,441 1,493
308 362 390 393 405 499 682 736 812 1,216 1,335 1,189 1,212
Operating Profit 58 85 87 91 95 118 164 257 430 326 348 252 281
OPM % 16% 19% 18% 19% 19% 19% 19% 26% 35% 21% 21% 17% 19%
1 2 2 2 1 2 4 40 6 14 9 14 21
Interest 13 12 10 8 8 8 15 10 6 3 3 4 2
Depreciation 10 10 11 13 14 16 23 27 29 35 45 59 70
Profit before tax 36 65 67 72 74 96 130 260 401 302 309 202 230
Tax % 33% 34% 32% 31% 32% 33% 36% 17% 26% 26% 26% 26%
24 43 45 50 50 64 84 215 295 225 229 149 168
EPS in Rs 4.69 8.41 8.91 9.77 9.87 12.61 16.42 42.21 57.91 44.04 44.75 29.12 32.90
Dividend Payout % 21% 19% 18% 41% 20% 22% 20% 19% 17% 23% 22% 34%
Compounded Sales Growth
10 Years: 12%
5 Years: 11%
3 Years: 5%
TTM: -4%
Compounded Profit Growth
10 Years: 13%
5 Years: 12%
3 Years: -20%
TTM: -2%
Stock Price CAGR
10 Years: 29%
5 Years: 36%
3 Years: -15%
1 Year: -15%
Return on Equity
10 Years: 25%
5 Years: 25%
3 Years: 19%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 97 130 165 189 235 287 355 526 782 980 1,159 1,257 1,302
146 151 135 111 120 181 165 87 47 23 88 3 2
79 98 93 95 147 159 218 160 306 359 335 314 391
Total Liabilities 332 388 402 406 512 637 749 783 1,145 1,371 1,592 1,584 1,705
126 155 151 187 220 355 376 423 458 629 719 1,089 1,064
CWIP 9 3 31 16 35 18 43 45 138 143 352 36 33
Investments 2 2 2 2 1 1 1 0 30 0 0 0 0
195 229 218 201 256 262 328 315 520 600 521 459 608
Total Assets 332 388 402 406 512 637 749 783 1,145 1,371 1,592 1,584 1,705

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
22 46 61 101 63 102 144 188 364 205 248 275
-27 -26 -31 -35 -65 -132 -67 -41 -213 -206 -277 -121
5 -13 -36 -68 -2 32 -60 -135 -86 -57 8 -140
Net Cash Flow 0 7 -6 -2 -3 2 17 12 65 -58 -21 13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 76 73 76 68 71 73 66 60 67 66 56 56
Inventory Days 141 133 105 92 165 99 88 67 91 76 82 85
Days Payable 73 79 58 63 120 78 104 57 133 105 84 85
Cash Conversion Cycle 143 128 123 96 116 94 51 71 25 36 53 56
Working Capital Days 105 96 93 87 84 76 56 54 34 40 46 47
ROCE % 21% 28% 26% 26% 24% 25% 29% 41% 56% 33% 28% 16%

Shareholding Pattern

Numbers in percentages

9 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
72.03% 72.03% 72.00% 71.99% 71.99% 71.98% 71.96% 71.96% 71.95% 71.95% 71.97% 71.97%
2.22% 2.22% 2.28% 2.32% 2.69% 2.79% 2.86% 2.92% 2.94% 3.04% 3.10% 3.20%
1.27% 1.05% 1.26% 1.11% 1.12% 1.15% 1.16% 1.13% 1.07% 1.11% 1.08% 1.53%
24.48% 24.70% 24.46% 24.57% 24.20% 24.08% 24.01% 24.00% 24.05% 23.91% 23.85% 23.31%
No. of Shareholders 1,93,5392,13,3052,15,3272,16,5122,08,3342,03,6772,01,8591,99,7811,97,1711,92,8851,87,0771,79,008

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls